RiverPark Advisors’s Core Laboratories CLB Stock Holding History

RiverPark Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-59,078	Closed	-$6.84M	–	54
2018 Q3	$6.84M	Sell	59,078 -55,922	-49%	-$6.31M	1.64%	23
2018 Q2	$14.5M	Sell	115,000 -32,000	-22%	-$3.89M	2.94%	14
2018 Q1	$15.9M	Sell	147,000 -85,000	-37%	-$9.41M	3.06%	15
2017 Q4	$25.4M	Sell	232,000 -31,000	-12%	-$3.09M	3.64%	11
2017 Q3	$26M	Sell	263,000 -52,000	-17%	-$5.04M	3.42%	15
2017 Q2	$31.9M	Sell	315,000 -277,500	-47%	-$29.9M	3.64%	12
2017 Q1	$68.4M	Buy	+592,500	New	+$68.9M	4.51%	10

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Epoch Investment Partners New York $17.6B AUM 34.16% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

RiverPark Advisors's CLB Position: Q4 2018 in Review

RiverPark Advisors sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 59,078 shares — an estimated $6.84M sold.

RiverPark Advisors first reported a position in CLB in Q1 2017 and held it in 7 quarters. The position peaked at $68.4M in Q1 2017. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

RiverPark Advisors reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
RiverPark Advisors sold 59,078 Core Laboratories shares in Q4 2018, an estimated $6.84M.
RiverPark Advisors first reported a position in Core Laboratories in Q1 2017 and held it in 7 quarters.
RiverPark Advisors's Core Laboratories position peaked at $68.4M in Q1 2017.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on RiverPark Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.